UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000029326 |
|---|---|
| Receipt number | R000033521 |
| Scientific Title | The search for biomarkers reflecting tumor immune microenvironment for renal cell carcinoma |
| Date of disclosure of the study information | 2017/12/01 |
| Last modified on | 2019/04/01 07:54:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The search for biomarkers reflecting tumor immune microenvironment for renal cell carcinoma
Acronym
The search for biomarkers reflecting tumor immune microenvironment for renal cell carcinoma
Scientific Title
The search for biomarkers reflecting tumor immune microenvironment for renal cell carcinoma
Scientific Title:Acronym
The search for biomarkers reflecting tumor immune microenvironment for renal cell carcinoma
Region
| Japan |
Condition
Condition
Renal cell carcinoma
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The search for biomarkers for renal cell carcinoma by comparing between tumor immune microenvironment, immune environment in peripheral blood, and clinical data.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Survival
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1.Patients with renal cell carcinoma who underwent surgery in Tokyo Medical and Dental University between 2007 and 2016.
2.Patients with renal cell carcinoma who undergo surgery and/or drug therapy in Tokyo Medical and Dental University
Key exclusion criteria
1.Patients with human immunodeficiency virus or acquired immunodeficiency syndrome and related disorders
2.Patients with hepatitis B surface antigen
3.Patients with hepatitis C virus antibody
4.Patients undergoing steroid therapy
5.Patients during pregnancy and lactation
Target sample size
600
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazutaka Saito |
Organization
Tokyo Medical and Dental University, Medical Hospital
Division name
Urology
Zip code
Address
1-5-45 Yushima, Bunkyo-ku, Tokyo,Japan
TEL
03-3813-6111
kz-saito.uro@tmd.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazutaka Saito |
Organization
Tokyo Medical and Dental University, Medical Hospital
Division name
Urology
Zip code
Address
1-5-45 Yushima, Bunkyo-ku, Tokyo,Japan
TEL
03-3813-6111
Homepage URL
kz-saito.uro@tmd.ac.jp
Sponsor or person
Institute
Tokyo Medical and Dental University, Medical Hospital
Institute
Department
Personal name
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2017 | Year | 09 | Month | 28 | Day |
Date of IRB
| 2017 | Year | 11 | Month | 30 | Day |
Anticipated trial start date
| 2018 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Research for immune environment for patients with renal cell carcinoma
Management information
Registered date
| 2017 | Year | 09 | Month | 28 | Day |
Last modified on
| 2019 | Year | 04 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033521
